SHLTN Stock Overview
Develops and markets personal telemedicine solutions in Israel, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SHL Telemedicine Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 2.65 |
| 52 Week High | CHF 5.90 |
| 52 Week Low | CHF 2.20 |
| Beta | 0.40 |
| 1 Month Change | 1.92% |
| 3 Month Change | 14.72% |
| 1 Year Change | -52.25% |
| 3 Year Change | -84.77% |
| 5 Year Change | -59.23% |
| Change since IPO | -93.54% |
Recent News & Updates
Recent updates
Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower
Oct 10
Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding
Aug 21Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher
Jun 04SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing
Apr 20We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 01Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?
Oct 28Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?
Jun 23SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Mar 05Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 12What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?
Jan 21Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%
Jan 04
What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?
Dec 01Shareholder Returns
| SHLTN | CH Healthcare | CH Market | |
|---|---|---|---|
| 7D | -1.5% | 1.3% | 2.3% |
| 1Y | -52.3% | 15.3% | 10.2% |
Return vs Industry: SHLTN underperformed the Swiss Healthcare industry which returned 13.9% over the past year.
Return vs Market: SHLTN underperformed the Swiss Market which returned 8.6% over the past year.
Price Volatility
| SHLTN volatility | |
|---|---|
| SHLTN Average Weekly Movement | 10.6% |
| Healthcare Industry Average Movement | 4.7% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 8.3% |
| 10% least volatile stocks in CH Market | 1.6% |
Stable Share Price: SHLTN's share price has been volatile over the past 3 months compared to the Swiss market.
Volatility Over Time: SHLTN's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swiss stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 583 | David Arnon | www.shl-telemedicine.com |
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio’B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices, including blood pressure, weighing, oxygen saturation level (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar measuring devices; and TelePress, a remote blood pressure monitoring device for personal use.
SHL Telemedicine Ltd. Fundamentals Summary
| SHLTN fundamental statistics | |
|---|---|
| Market cap | CHF 41.80m |
| Earnings (TTM) | -CHF 8.03m |
| Revenue (TTM) | CHF 50.82m |
0.9x
P/S Ratio-5.4x
P/E RatioIs SHLTN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHLTN income statement (TTM) | |
|---|---|
| Revenue | US$55.94m |
| Cost of Revenue | US$30.36m |
| Gross Profit | US$25.58m |
| Other Expenses | US$34.42m |
| Earnings | -US$8.84m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Apr 24, 2025
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 45.73% |
| Net Profit Margin | -15.80% |
| Debt/Equity Ratio | 15.9% |
How did SHLTN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 08:37 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SHL Telemedicine Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carla Bänziger | Bank Vontobel AG |
| Theodore O'Neill | Litchfield Hills Research, LLC |